Last $0.0086 USD
Change Today +0.0016 / 22.86%
Volume 1.6M
OCLG On Other Exchanges
Symbol
Exchange
OTC US
As of 3:59 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

oncologix tech inc (OCLG) Snapshot

Open
$0.0080
Previous Close
$0.0070
Day High
$0.0089
Day Low
$0.0070
52 Week High
11/5/13 - $0.03
52 Week Low
04/10/14 - $0.0028
Market Cap
1.1M
Average Volume 10 Days
2.7M
EPS TTM
$-0.02
Shares Outstanding
126.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ONCOLOGIX TECH INC (OCLG)

Related News

No related news articles were found.

oncologix tech inc (OCLG) Related Businessweek News

No Related Businessweek News Found

oncologix tech inc (OCLG) Details

Oncologix Tech, Inc., through its subsidiaries, manufactures medical devices, and provides personal care services. The company operates in two segments, Medical Device Manufacturing and Personal Care Services. The Medical Device Manufacturing segment designs, develops, manufactures and distributes the Toxygen hardware system with disposables speculums and tubing. Its products are primarily used for colon and bowel preparation prior to medical procedures, such as a colonoscopy and OB/GYN medical procedures, as well as for individuals seeking health and wellness prevention and good colon health. The Personal Care Services segment provides non-medical, personal care attendant services, supervised independent living, long-term senior care, and other approved programs. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Pineville, Louisiana.

170 Employees
Last Reported Date: 04/1/14
Founded in 1995

oncologix tech inc (OCLG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $58.8K
Chief Financial Officer and Controller
Total Annual Compensation: $80.1K
Compensation as of Fiscal Year 2013.

oncologix tech inc (OCLG) Key Developments

Oncologix Tech, Inc. Announces Revenue Results for the Second Quarter and Half Year Ended February 28, 2014

Oncologix Tech, Inc. announced revenue results for the second quarter and half year ended February 28, 2014. Revenues for the quarter were $983,758 compared to zero revenues for the comparable period in fiscal 2013. For the half year, the company reported revenue of $1,708,391 compared to zero revenues for the comparable periods in fiscal 2013.

Oncologix Tech, Inc. announced delayed 10-Q filing

On 04/14/2014, Oncologix Tech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Oncologix Tech, Inc. Approves Amendments to its Articles of Incorporation

Oncologix Tech, Inc. announced that Board of Directors and shareholders holding a majority of outstanding voting capital stock have approved an amendment to the articles of incorporation to increase the total authorized common stock from 200 million shares of common stock, par value $0.001, to 750 million shares of common stock and to approve the 2013 Omnibus Incentive Plan.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLG:US $0.01 USD +0.0016

OCLG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OCLG.
View Industry Companies
 

Industry Analysis

OCLG

Industry Average

Valuation OCLG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLOGIX TECH INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.